LENZ Therapeutics, Inc.
LENZ
$29.52
$0.642.22%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 217.70% | 146.28% | -- | 379.91% | 48.05% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 91.24% | 101.80% | -- | -- | -34.09% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 215.15% | 145.56% | -- | -- | 44.17% |
|
|
|||||
| Total Current Assets | 215.15% | 145.56% | -- | -- | 44.17% |
| Net Property, Plant & Equipment | 434.68% | 365.77% | -- | -- | 33.33% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -49.35% | -25.91% | -- | -- | 8,803.23% |
| Total Assets | 205.93% | 143.02% | -- | -- | 49.89% |
|
|
|||||
| Total Accounts Payable | -25.46% | -46.35% | -- | -- | 20.11% |
| Total Accrued Expenses | -55.93% | -62.47% | -- | -- | 194.97% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 313.87% | 369.92% | -- | -- | 33.01% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -43.79% | -54.23% | -- | -- | 94.90% |
|
|
|||||
| Total Current Liabilities | -43.79% | -54.23% | -- | -- | 94.90% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 323.96% | 319.82% | -- | -- | 30.61% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -54.29% | -- | -- | 83.33% |
| Total Liabilities | -40.40% | -49.30% | -- | -- | 93.85% |
|
|
|||||
| Common Stock & APIC | 4,040.29% | 4,299.48% | -- | -- | 20.25% |
| Retained Earnings | -52.25% | -84.98% | -- | -- | -276.81% |
| Treasury Stock & Other | 3,166.67% | 10,560.00% | -- | -- | -- |
| Total Common Equity | 335.09% | 438.13% | -- | 1,184.72% | -375.19% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | 152.21% |
| Preferred Stock, Others | -- | -- | -- | -- | -12.37% |
| Total Preferred Equity | -- | -- | -- | -- | 149.26% |
|
|
|||||
| Total Common Equity | 335.09% | 438.13% | -- | 1,184.72% | -375.19% |
| Total Preferred Equity | -- | -- | -- | -- | 149.26% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 295.90% | 187.19% | -- | 432.15% | 38.43% |
|
|
|||||